Journal List > J Korean Ophthalmol Soc > v.49(12) > 1008156

Chang, Kim, Yu, and Kwak: Comparison of Silicone Oil Removal Using 23-Gauge and 20-Gauge System for Pars Plana Vitrectomy

Abstract

Purpose

The purpose of this study was to compare the clinical results of silicone oil removal using a 23-gauge transconjunctival sutureless pars plana vitrectomy (TSVS) and the 20-gauge pars plana vitrectomy (PPV) system and to evaluate the clinical value of 23-guage PPV system in silicone oil removal.

Methods

Eight eyes of 8 patients who received removal of silicone oil using the 23-gauge TSVS and 6 eyes of 6 patients using the 20-gauge PPV system were included in this study. The total operation time, silicone oil removal time, intraoperative and postoperative advantages, shortcomings, and complications were compared.

Results

The operation time and silicone oil removal time were 44.6±14.1 minutes, 42.7±10.5 minutes and 2.0±0.9 min/cc, 1.4±0.6 min/cc when silicone oil removal was performed using 23-gauge TSVS and 20-gauge PPV system, respectively. They were not significantly different ( p=0.80, 0.22). Attention for the complete removal of the oil is necessary because of the intraocular trocar length when the 23-gauge TSVS is used. There were no complications except transient hypotonies (2 eyes), transient hypertonies (2 eyes) in the 23-gauge system and transient hypertonies (2 eyes) in the 20-gauge system.

Conclusions

The operation time for silicone oil removal using the 23-gauge TSVS was not different than that of the 20-gauge PPV system and can be performed safely without any particular complications. Care and precautionary measures are needed in order to remove silicone oil completely.

References

1. Casswell AG, Gregor ZJ. Silicone oil removal. II. Operative and postoperative complications. Br J Ophthalmol. 1987; 71:898–902.
crossref
2. Chen JC. Sutureless pars plana vitrectomy through self-sealing sclerotomies. Arch Ophthalmol. 1996; 114:1273–5.
crossref
3. Milibak T, Suveges I. Complications of sutureless pars plana vitrectomy through self-sealing sclerotomies. Arch Ophthalmol. 1998; 116:119.
4. Kwok AK, Tham CC, Lam DS. . Modified sutureless sclerotomies in pars plana vitrectomy. Am J Ophthalmol. 1999; 127:731–3.
crossref
5. Schmidt J, Nietgen GW, Brieden S. Self-sealing, sutureless sclerotomy in pars plana vitrectomy in German. Klin Monatsbl Augenheilkd. 1999; 215:247–51.
6. Jackson T. Modified sutureless sclerotomies in pars plana vitrectomy. Am J Ophthalmol. 2000; 129:116–7.
crossref
7. Assi AC, Scott RA, Charteris DG. Reversed self-sealing parsplana sclerotomies. Retina. 2000; 20:689–92.
8. Rahman R, Rosen PH, Riddell C, Towler H. Self-sealing sclerotomies for sutureless pars plana vitrectomy. Ophthalmic Surg Lasers. 2000; 31:462–6.
crossref
9. Theelen T, Verbeek AM, Tilanus MA, van den Biesen PR. A novel technique for self-sealing, wedge-shaped pars plana sclerotomies and its features in ultrasound biomicroscopy and clinical outcome. Am J Ophthalmol. 2003; 136:1085–92.
crossref
10. Yanyali A, Celik E, Horozoglu F, Nohutcu AF. Corneal topographic changes after transconjunctival (25-gauge) sutureless vitrectomy. Am J Ophthalmol. 2005; 140:939–41.
crossref
11. Lakhanpal RR, Humayun MS, de Juan E Jr. . Outcomes of 140 consecutive cases of 25-gauge transconjunctival surgery for posterior segment disease. Ophthalmology. 2005; 112:817–24.
crossref
12. Meyer CH, Rodrigues EB, Schmidt JC. . Sutureless vitrectomy surgery. Ophthalmology. 2003; 110:2427–8.
crossref
13. Lam DS, Yuen CY, Tam BS. . Sutureless vitrectomy surgery. Ophthalmology. 2003; 110:2428–9.
crossref
14. Kapran Z, Acar N. Removal of silicone oil with 25-gauge transconjunctival sutureless vitrectomy system. Retina. 2007; 27:1059–64.
crossref
15. Cibis PA, Becker B, Okun E, Canaan S. The use of liguid silicone in retinal detachment surgery. Arch Ophthalmol. 1962; 68:590–9.
16. Lucke K, Laqua H. Silicone oil in the treatment of complicated retinal detachment. 1st. Vol. 1. Berlin, New York: Springer;1990. p. 121.
crossref
17. Bodanowitz S, Kir N, Hesse L. Silicone oil for recurrent vitreous hemorrhage in previously vitrectomized diabetic eyes. Ophthalmologica. 1997; 211:219–22.
crossref
18. Hoerauf H, Roider J, Bopp S. . Endotamponade with silicone oil in severe proliferative retinopathy with attached retina. Ophthalmologe. 1995; 92:657–62.
19. Riedel KG, Gabel VP, Neubauer L. . Intravitreal silicone oil injection: complications and treatment of 415 consecutive patients. Graefes Arch Clin Exp Ophthalmol. 1990; 228:19–23.
crossref
20. Eller AW, Gardner TW, D'Antonio JA. A survey of intraocular silicone oil use in the united states. Ophthalmology. 1992; 99:1174–6.
crossref
21. Oh TS, Kim SY. Complications associated with intravitreal silicone oil injection. J Korean Ophthalmol Soc. 1993; 34:1012–22.
22. Pearson RV, McLeod D, Gregor ZJ. Removal of silicone oil following diabetic vitrectomy. Br J ophthalmol. 1993; 77:204–9.
crossref
23. Ekcardt C. Transconjunctival sutureless 23-gauze vitrectomy. Retina. 2005; 25:208–11.

Figure 1
. The photograph of silicone removal using 23-gauge vitrectomy system in a patient with proliferative diabetic retinopathy patient.
jkos-49-1929f1.tif
Figure 2
. Shortcoming of silicone removal using 23-gauge vitrectomy system (A) compared with 20-gauge vitrectomy system (B). In 23-gauge system, we need some attentions to remove silicone oil completely because of the intraocular trocar length but we can remove oil nearly completely by pulling the needle in 20-gauge system.
jkos-49-1929f2.tif
Table 1.
Characteristics of patients of silicone oil removal using 23-gauge transconjunctival sutureless vitrectomy system and 20-gauge vitrectomy system
Silicone oil removal using 23-gauge TSVS patient Silicone oil removal using 20-gauge VS patient p-value
Male:Female 3:5 1:5
Age (years) 49.75±19.52 50.17±12.29 1
Injected silicone oil volume (cc) 4.63±1.07 4.5±0.43 0.79

TSVS=transconjunctival sutureless vitrectomy system;

VS=vitrectomy system;

by Mann-Whitney U test.

Table 2.
The mean operation time, silicone removal/injection time of patient silicone oil removal using 23-gauge transconjunctival sutureless vitrectomy system and 20-gauge vitrectomy system
Silicone oil removal using 23-gauge TSVS patient Silicone oil removal using 20-gauge VS patient p-value
Mean operation time (min) 44.6±14.1 42.7±10.5 0.80
Siicone oil removal time (min/cc) 2.0±0.9 1.4±0.6 0.22

TSVS=transconjunctival sutureless vitrectomy system;

VS=vitrectomy system

by Mann-Whitney U test.

Table 3.
The mean preoperative, postoperative 1-day, 1-week, 1-month intraocular pressure after silicone oil removal using 23-gauge transconjunctival sutureless vitrectomy system and 20-gauge vitrectomy system
IOP (mmHg) Silicone oil removal using 23-gauge TSVS patient Silicone oil removal using 20-gauge VS patient p-value
Preoperative 15.9±8.5 17.2±7.5 0.52
Postoperative 1day 12.2±5.8 18.7±2.9 0.03
Postoperative 1 week 14.0±5.9 12.5±3.4 0.79
Postoperative 1 month 11.6±5.1 19.4±8.8 0.10

TSVS=transconjunctival sutureless vitrectomy system

VS=vitrectomy system

by Mann-Whitney U test.

TOOLS
Similar articles